Resource Summary

Clinical Question:
Does “bioidentical hormone” micronized progesterone (MP) instead of “synthetic hormone” medroxyprogesterone acetate (MPA) result in improved menopausal symptom control and/or reduction in harm?

Bottom-line:
The theory behind bioidentical hormone use is appealing; however its clinical advantage is not supported by reliable evidence. Long-term safety is largely unknown.



*** Original Documents can be found and downloaded using the link provided below ***

https://www.acfp.ca/tools-for-practice/

Publication Date: 2012-3-5
Last Updated on PCR: 2017-03-31 15:26:24